Peptide record

TPDB91440

linear (RW)4-Dox Antibacterial Anticancer Antifungal Antiviral Cell-penetrating Peptides Toxicity modified_plain modified
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91440
linear (RW)4-Dox
Antibacterial Anticancer Antifungal Antiviral Cell-penetrating Peptides Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 Peptipedia CancerPPD 2.0 SATPdb dbACP CAFPdb DRAMP dbAMP CellPPD-MOD CPPsite3.0 PerseuCPP
modified_plain
Yes
A 8-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CancerPPD 2.0, and other sources, with an available 3D structural model.
Chemical: Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]
Sequence
RWRWRWRW
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
8 reviewed residue count
Free Activity
Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ] Activity
L Activity
Linear Activity
Free Activity
Anticancer Activity
Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

46-69% antiproliferative activity at 1 µM
Anticancer

Target

Leukemia Cancer
CCRF-CEM
Blood

Assay & Model

MTT/MTS assay
72 to 120-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

28-34% antiproliferative activity at 1 µM
Anticancer

Target

Ovarian Cancer
SK-OV-3
Ovary

Assay & Model

MTT/MTS assay
72 to 120-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013
Evidence 3 Activity

Activity

21-61% antiproliferative activity at 1 µM
Anticancer

Target

Colon Cancer
HCT-116
Colon

Assay & Model

MTT/MTS assay
72 to 120-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013
Evidence 4 Activity

Activity

60-74% antiproliferative activity at 1 µM
Anticancer

Target

Breast Cancer
MDA-MB-468
Breast

Assay & Model

MTT/MTS assay
72 to 120-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013